GeminIQ Website Logo

Viewing OPRX free

Start free trial

Subscribe for full history, 90+ metrics, screener, watchlist...

OptimizeRx Corp

OPRX

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Short Term Investments
-----------54
Cash And Cash Equivalents At Carrying Value
242023201717131615151410
Accounts Receivable Net Current
253238323433382625303621
Income Taxes Receivable
21121000211-
Prepaid Expense And Other Assets Current
------24523-
Prepaid Expense Current
3333322----3
Assets Current
545665565452544746485487
Property Plant And Equipment Net
000000000000
Other Assets
Finite Lived Patents Gross
-----------2
Deferred Costs
-----------0
Other Intangible Assets Net
--------1415343
Goodwill
717171717171717178787823
Finite Lived Intangible Assets Net
-40-555-6----
Operating Lease Right Of Use Asset
000010000110
Other Long Term Investments
--------01-1
Security Deposit
------00--1-
Deposits Assets Noncurrent
----------1-
Other Assets
110111112114115116117---12936
Assets
164167177170169168171165173176183124
Liabilities And Stockhold…
Liabilities Current
Long Term Debt Current
12433322342-
Accounts Payable Trade Current
132223233221
Accrued Liabilities Current
541210129865783
Taxes Payable Current
--00000--00-
Operating Lease Liability Current
000000000000
Non Current Liabilities
Deferred Revenue Current
--------1100
Contract With Customer Liability Current
111001011100
Liabilities Current
10102118211819151517188
Liabilities Noncurrent
Long Term Debt Noncurrent
1821212525293133323234-
Operating Lease Liability Noncurrent
000000000000
Deferred Income Tax Liabilities Net
66643443444-
Liabilities
33384948505154515254578
Stockholders Equity
Preferred Stock Value
0000000-----
Common Stock Value
000000000000
Treasury Stock Common Value
---0----0-----
Treasury Stock Value
-0-0--0-0-0-0-0-0-0-0-0
Additional Paid In Capital
211209208207204203201199196194191176
Retained Earnings Accumulated Deficit
-80-80-79-84-85-87-84-84-75-71-64-60
Stockholders Equity
131130128122119116117114121123127116
Liabilities And Stockholders Equity
164167177170169168171165173176183124
Allowance For Doubtful Accounts Receivable
--------00--
Allowance For Doubtful Accounts Receivable Current
000000000001
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
0000000000--
Preferred Stock Shares Outstanding
0000000000--
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
167167167167167167167167167167167167
Shares Outstanding
1919---18-----18
Common Stock Shares Issued
212121202020202020202018
Treasury Stock Common Shares
2-222-222222

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20263.86%25.81%27.44%---------
202532.79%21.98%13.53%4.45%8.55%25.32%-2.43%-20.26%-23.83%10.62%12.98%-12.48%
2024-15.57%-24.30%-26.73%-10.24%-10.24%-38.69%32.02%35.22%36.70%-7.51%13.65%66.33%
2023----32.78%-42.00%-32.46%4.14%40.51%55.67%4.75%7.75%-3.39%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
5.58
5.37
3.04
3.05
2.57
2.82
2.89
3.23
3.07
2.88
3.04
11.35
Quick Ratio
5.27
5.07
2.91
2.90
2.41
2.69
2.77
2.93
2.76
2.74
2.86
10.96
Working Capital
44.44M
45.71M
43.45M
37.85M
33.02M
33.36M
35.32M
32.40M
31.01M
31.59M
36.45M
79.69M
Leverage & Debt
Debt to Equity
0.25
0.29
0.38
0.39
0.42
0.44
0.46
0.44
0.43
0.44
0.45
0.07
Interest Coverage TTM
1.80
2.75
2.21
0.69
-1.13
-1.82
-2.23
-6.59
-8.23
-15.76
-
-
Debt Ratio
0.20
0.23
0.27
0.28
0.30
0.31
0.32
0.31
0.30
0.31
0.31
0.06
Efficiency & Turnover
Asset Turnover TTM
0.60
0.64
0.63
0.64
0.60
0.55
0.52
0.56
0.52
0.51
0.45
0.49
Days Sales Outstanding TTM
105.63
110.01
126.69
99.62
103.32
120.81
147.51
105.62
102.09
111.80
149.04
111.03
Receivables Turnover TTM
3.46
3.32
2.88
3.66
3.53
3.02
2.47
3.46
3.58
3.26
2.45
3.29
Per Share Metrics
Diluted EPS TTM
0.24
0.36
0.27
0.00
-0.52
-0.83
-1.10
-1.32
-0.98
-0.99
-1.03
-0.83
Free Cash Flow Per Share TTM
0.98
0.76
1.01
0.63
0.56
0.35
0.26
-0.09
-0.11
-0.28
-0.43
0.10
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
65.25%
70.04%
67.25%
65.61%
64.69%
64.13%
64.45%
61.88%
61.14%
60.95%
59.98%
60.09%
Operating Profit Margin TTM
8.34%
13.22%
10.69%
3.60%
-6.58%
-11.42%
-14.88%
-37.19%
-33.07%
-31.16%
-36.91%
-20.50%
Net Profit Margin TTM
4.57%
6.37%
4.69%
0.03%
-9.63%
-16.33%
-21.83%
-29.66%
-23.41%
-23.10%
-24.56%
-21.64%
Growth Metrics
Net Revenue Growth (1Y)
-1.73%
13.76%
18.78%
31.63%
33.97%
20.66%
28.81%
28.27%
22.84%
26.71%
14.53%
4.83%
Net Income Growth (1Y)
-146.62%
-144.36%
-125.52%
-100.14%
-44.90%
-14.71%
14.48%
75.81%
24.82%
28.36%
53.57%
31.09%
EPS Growth (1Y)
-145.93%
-143.67%
-125.16%
-100.13%
-45.66%
-16.09%
7.17%
59.63%
16.17%
20.76%
59.48%
41.67%
Valuation Metrics
P/E TTM
23.35
17.24
44.33
11,539.76
-25.32
-10.38
-4.42
-5.85
-10.19
-12.22
-13.95
-9.41
P/B TTM
0.82
0.91
1.77
3.11
2.09
1.38
0.76
1.24
1.51
1.80
1.94
1.11
P/S TTM
1.07
1.10
2.08
3.55
2.44
1.70
0.97
1.74
2.39
2.82
3.43
2.04
Market Cap
107.45M
117.82M
227.49M
380.81M
249.90M
159.96M
88.90M
141.46M
182.58M
220.77M
245.06M
129.44M
Enterprise Value
102.36M
121.00M
229.80M
389.39M
261.74M
175.87M
108.34M
160.61M
203.22M
241.50M
267.43M
119.52M
Calculated Values
Free Cash Flow TTM
18.36M
14.33M
18.66M
11.76M
10.34M
6.53M
4.78M
-1.67M
-2.00M
-5.13M
-7.33M
1.72M
Net Debt
-5.09M
3.17M
2.31M
8.58M
11.84M
15.92M
19.44M
19.15M
20.64M
20.74M
22.38M
-9.92M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-19Sale
Owner: Stelmakh, Edward
Title: Chief Finance & Strat Officer
Shares: 1,388
Price/Share: $13.51
Value: $18,751.88
Shares Owned: 126,830
Relationship: Officer
Ownership: Direct
2025-10-03Sale
Owner: Silvestro, Stephen L
Title: Chief Executive Officer
Shares: 1,620
Price/Share: $18.75
Value: $30,375.00
Shares Owned: 188,916
Relationship: Officer
Ownership: Direct
2025-08-28Sale
Owner: Spangler, Patrick D
Title: -
Shares: 11,120
Price/Share: $17.49
Value: $194,488.80
Shares Owned: 44,215
Relationship: Director
Ownership: Direct
2025-03-14Purchase
Owner: Lang, James Paul
Title: -
Shares: 321,408
Price/Share: $7.60
Value: $2,442,700.80
Shares Owned: 389,452
Relationship: Director
Ownership: Direct
2024-12-12Purchase
Owner: Febbo, William J
Title: CEO
Shares: 20,000
Price/Share: $5.01
Value: $100,200.00
Shares Owned: 601,253
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart
2026-03-31
70.96%
Inst. Shares: 13,313,566
Shares Outstanding: 18,761,622
2025-12-31
70.38%
Inst. Shares: 13,058,735
Shares Outstanding: 18,555,343
2025-09-30
70.55%
Inst. Shares: 13,105,695
Shares Outstanding: 18,576,199
2025-06-30
65.77%
Inst. Shares: 12,174,673
Shares Outstanding: 18,510,834
2025-03-31
53.32%
Inst. Shares: 9,848,476
Shares Outstanding: 18,470,808

OptimizeRx Corp (OPRX) — SEC Financial Statements & Analysis

OptimizeRx Corp (OPRX) is a services-business services, nec company, incorporated in NV. OptimizeRx Corp trades on Nasdaq as: OPRX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), OptimizeRx Corp reported a -1.73% year-over-year revenue growth, a Gross Profit Margin of 65.25% (TTM), a Debt-to-Equity ratio of 0.25x, a Price-to-Sales (P/S) ratio of 1.07x (TTM), a Price-to-Book (P/B) ratio of 0.82x (TTM), at a market cap of $107.45M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-1.73%
Gross Profit Margin TTM
65.25%
Debt To Equity
0.25x
P/S TTM
1.07x
P/B TTM
0.82x
Market Cap
$107.45M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is OptimizeRx Corp in?

OptimizeRx Corp (OPRX) operates in the Services-Business Services, NEC industry.

What is OPRX's market cap?

OptimizeRx Corp (OPRX) has a market capitalization of $107.45M as of 2026-06-30.

What is OPRX's P/E ratio?

OptimizeRx Corp (OPRX)'s trailing twelve month P/E ratio is 23.35x as of 2026-06-30.

What exchange does OPRX trade on?

OptimizeRx Corp (OPRX) trades on the Nasdaq.

Where is OptimizeRx Corp incorporated?

OptimizeRx Corp is incorporated in NV.

Companies in Services-Business Services, NEC

MDCEMedical Care Technologies Inc.VVISA INC.MAMastercard IncRPAYRepay Holdings CorpUBERUber Technologies, IncACNAccenture plc

Wall Street's data.
Main Street's price.

Start 7-day free trial